NCT06717061

Brief Summary

People who will be eligible to be asked about participation in the research project are individuals who seek planned care for surgery on their gallbladder due to gallstone disease. The group of patients is chosen as they can represent a normal material that enables comparison with hernia-specific disease in the abdominal wall. Basic data such as height, weight, sex, age, medication and ASA class will be collected in the form of a study form and stored in a database in a pseudonymised form. During the sampling of biological material, the test subjects will be under general anesthesia, which is why the sampling will not mean increased pain or discomfort other than what is standard after a gallbladder operation with the minimally invasive technique. No additional wound area will be added to the test subjects as the sample pieces are taken from the area at the umbilicus where one operates by default. The sampling is not planned to be repeated, but is performed at the time when the patients perform their cholecystectomy. During the sampling, centimeter-sized pieces of skin, fatty tissue, connective tissue and muscle are taken. Furthermore, serum and plasma will be collected. Two tubes of blood samples (10 ml total) are taken, centrifuged and pipetted before being frozen for later analysis. Pieces of tissue are placed in formalin before transport to the laboratory. The study form regarding the patient\'s basic state of health will be filled in by the operator on the day of surgery and will be stored pseudonymized when the research subject is assigned a study number. Patients who are troubled by gallstone disease and are referred for minimally invasive surgery of the gallbladder at the surgical center Västerbotten in Skellefteå will receive oral and written information and will be asked to participate in the study. Approximately 200 cholecystectomies are performed annually at Skellefteå hospital. We understand that within a reasonable period of time it will be possible to include 40 patients, which is the goal, also taking into account the exclusion criteria that exist. The inclusion of patients is expected to take approximately one year

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
7mo left

Started Apr 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Apr 2024Nov 2026

Study Start

First participant enrolled

April 10, 2024

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 4, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2025

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 18, 2026

Expected
Last Updated

December 4, 2024

Status Verified

November 1, 2024

Enrollment Period

1.7 years

First QC Date

August 19, 2024

Last Update Submit

November 29, 2024

Conditions

Keywords

hernia

Outcome Measures

Primary Outcomes (1)

  • Collagen composition differs between patients with abdominal wall hernia compared to patients without abdominal wall hernias

    Are there detectable differences in collagen composition in the normal abdominal wall compared to patients who developed a primary or secondary abdominal wall hernia or abdominal rectus diastasis?

    Five years from enrollment

Secondary Outcomes (1)

  • Collagen turnover differs between patients with abdominal wall hernia compared to patients without abdominal wall hernias

    Five years from enrollment.

Study Arms (1)

Harvesting of study samples during planned intervention

Patients who are troubled by gallstone disease and are referred for laparoscopic surgery of the gallbladder at the surgical center Västerbotten in Skellefteå will receive oral and written information and will be asked to participate in the study. Once the blood samples have been taken, a research nurse will be on site in Skellefteå to collect the samples for centrifugation, pipetting and freezing. Serum and plasma will be shipped frozen to Umeå for analysis. Pieces of tissue are placed in formalin in the operating room and sent to the laboratory.

Procedure: Harvesting of biological material

Interventions

During the sampling of biological material, the test subjects will be under general anesthesia, which is why the sampling will not mean increased pain or discomfort other than what is standard after a gallbladder operation with the peephole technique. . The sampling is not planned to be repeated, but is performed at the time when the patients perform their biliary surgery. During the sampling, centimeter-sized pieces of skin, fatty tissue, connective tissue and muscle are taken. Furthermore, serum and plasma will be collected. Two tubes of blood samples (10 ml total) are taken, centrifuged and pipetted before being frozen for later analysis. Pieces of tissue are placed in formalin before transport to the laboratory. The study form regarding the patient\'s basic state of health will be filled in by the operator on the day of surgery.

Harvesting of study samples during planned intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

People who will be eligible to be asked about participation in the research project are individuals who seek planned care for surgery on their gallbladder due to gallstone disease. The group of patients is chosen as they can represent a normal material that enables comparison with hernia-specific disease in the abdominal wall

You may qualify if:

  • \- Individuals seeking planned care for surgery on their gallbladder due to gallstone disease

You may not qualify if:

  • Disseminated cancer,
  • Ongoing acute inflammation of the gallbladder,
  • Known connective tissue disease,
  • Cortisone medication,
  • BMI \>35,
  • Clinically measured rectus diastasis of \>4 cm and/or concurrent abdominal wall hernia
  • Patients operated for abdominal wall hernia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kirurgcentrum Västerbotten

Skellefteå, Sweden

Location

Biospecimen

Retention: SAMPLES WITH DNA

serum, plasma skin fascia muscle

MeSH Terms

Conditions

Hernia

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2024

First Posted

December 4, 2024

Study Start

April 10, 2024

Primary Completion

December 10, 2025

Study Completion (Estimated)

November 18, 2026

Last Updated

December 4, 2024

Record last verified: 2024-11

Locations